Amarantus Bioscience Holdings Inc (AMBS)

[dangerx]

Just look at the market cap even at these new levels. Does anybody recall what was paid for the license to the Phenoguard Cell Line? That thing alone is worth something, but the thought of getting MANF to human trials is chilling. I'm guessing this train stops somewhere between 10 and 30 mln for the market cap... Could go anywhere from .10 to .30 depending on how much faith investors have in the clinical possibilities of MANF.

And that get's us back to stage 1, where this whole boat started for me last year.